1.	Tu W-J, Zeng X, Liu Q. Aging tsunami coming: the main finding from China’s seventh national population census. Aging clinical and experimental research 2022; 34(5): 1159-63.
2.	ESCAP. Ageing in Asia and the Pacific: Key Facts. 2022. https://www.population-trends-asiapacific.org/data.
3.	Liu Y, Wu Y, Chen Y, et al. Projection for dementia burden in China to 2050: a macro-simulation study by scenarios of dementia incidence trends. The Lancet Regional Health–Western Pacific 2024; 50.
4.	Fang EF, Xie C, Schenkel JA, et al. A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks. Ageing Res Rev 2020; 64: 101174.
5.	Eberstadt N, Verdery A. China’s Revolution in Family Structure: A Huge Demographic Blind Spot with Surprises Ahead. 2023.
6.	Liu J. Filial piety, love or money? Foundation of old-age support in urban China. Journal of Aging Studies 2023; 64: 101104.
7.	Xiang Q, Wang R, Yan C, Li A, Wang J. Status and influencing factors of health poverty of empty nesters in China. Medicine and Society 2020; 33(9): 58-62.
8.	Ministry of Civil Affairs and National Health Commission. Bulletin of Basic Data from the Fifth Sample Survey on the Living Conditions of Urban and Rural Senior Residents, 2024.
9.	Xue Q, Witvorapong N. Effects of Socioeconomic Status on Aging People’s Health in China. Journal of Family and Economic Issues 2022; 43(3): 476-88.
10.	Chu L. Gender disparities in health and well-being among older adults in China. Journal of Women & Aging 2023; 35(3): 299-317.
11.	Peng R, Huang J, Deng X. Spatiotemporal evolution and influencing factors of the allocation of social care resources for the older adults in China. International Journal for Equity in Health 2023; 22(1): 222.
12.	Li H, Zeng Y, Gan L, et al. Urban-rural disparities in the healthy ageing trajectory in China: a population-based study. BMC Public Health 2022; 22(1): 1406.
13.	Luyi H. A Study of Age Discrimination and China Status Quo.  Equality and Anti-Discrimination: Brill Nijhoff; 2021: 265-90.
14.	Cheng J, Li R. Reasons for the low labor participation rate of the retirees in urban China: The challenges and direction of the human resources development of middle-aged and senior people. J of Beijing Normal University (Social Sciences) 2022; 2022(2): 143-55.
15.	Sen K, Prybutok G, Prybutok V. The use of digital technology for social wellbeing reduces social isolation in older adults: A systematic review. SSM-population health 2022; 17: 101020.
16.	Khan HT. Population ageing in a globalized world: Risks and dilemmas? Journal of evaluation in clinical practice 2019; 25(5): 754-60.
17.	Martinez-Lacoba R, Pardo-Garcia I, Escribano-Sotos F. Aging, dependence, and long-term care: A systematic review of employment creation. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2021; 58: 00469580211062426.
18.	Gong J, Wang G, Wang Y, Zhao Y. Consumption and poverty of older Chinese: 2011–2020. The Journal of the Economics of Ageing 2022; 23: 100410.
19.	Hu Y, Han H, Liu P. Reducing multidimensional poverty of elderly: the role of the new rural pension scheme in China. Discrete Dynamics in Nature and Society 2022; 2022(1): 4533075.
20.	WHO. UN Decade of Healthy Ageing. https://www.who.int/initiatives/decade-of-healthy-ageing (Accessed on 29 Jan 2024).
21.	Zeng Y, Hesketh T. The effects of China's universal two-child policy. The Lancet 2016; 388(10054): 1930-8.
22.	Hu Z, Peng, X., & Wu, Y. The Chinese strategies for actively responding to population ageing. Social Sciences in China 2022; 43(4): 46-66.
23.	The State Council of the People’s Republic of China. China releases 5-year plan on elderly care. 2022. https://english.www.gov.cn/news/topnews/202203/02/content_WS621ea784c6d09c94e48a5b80.html#:~:text=China%20releases%205%2Dyear%20plan%20on%20elderly%20care&text=BEIJING%20%E2%80%94%20China%20has%20released%20a,of%20the%20country's%20aging%20population.
24.	Su B, Luo Y, Tian Y, Chen C, Zheng X. Confronting COVID-19 and prioritizing aging population. China CDC Weekly 2023; 5(10): 229.
25.	Yuan J, Li M, Lu ZK. National value-based pricing negotiation for oncology drugs — lessons from China. Nature Reviews Clinical Oncology 2023; 20(8): 501-2.
26.	Qian M, Zhang X, Chen Y, Xu S, Ying X. The pilot of a new patient classification-based payment system in China: The impact on costs, length of stay and quality. Soc Sci Med 2021; 289: 114415.
27.	Li Q, Fan X, Jian W. Impact of Diagnosis-Related-Group (DRG) payment on variation in hospitalization expenditure: evidence from China. BMC Health Services Research 2023; 23(1): 688.
28.	Zhu D, Shi X, Chen S, Ye X, Nicholas S, He P. The role of primary health care in improving health status, financial protection and health equity in the context of China's health system reform. Int J Health Plann Manage 2024; 39(2): 311-28.
29.	Ren Y, Zhou Z, Cao D, et al. Did the Integrated Urban and Rural Resident Basic Medical Insurance Improve Benefit Equity in China? Value in Health 2022; 25(9): 1548-58.
30.	Tao W, Zeng Z, Dang H, et al. Towards universal health coverage: lessons from 10 years of healthcare reform in China. BMJ Global Health 2020; 5(3): e002086.
31.	Yip W, Fu H, Chen AT, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet 2019; 394(10204): 1192-204.
32.	National Healthcare Security Administration (NHSA). Official Announcements and Policy Documents, 2023–2025. 2025. https://www.nhsa.gov.cn/col/col196/index.html.
33.	Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University–Lancet Commission. The Lancet 2022; 400(10367): 1967-2006.
34.	Li Q, Chen Y, Zhang Y, Liu X. Evaluation of China’s long-term care insurance policies. Frontiers in Public Health 2024; 12: 1252817.
35.	Mendelson A, Kondo K, Damberg C, et al. The Effects of Pay-for-Performance Programs on Health, Health Care Use, and Processes of Care: A Systematic Review. Ann Intern Med 2017; 166(5): 341-53.
36.	Shrank WH, Choudhry NK, Liberman JN, Brennan TA. The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff (Millwood) 2011; 30(7): 1351-7.
37.	National Healthcare Security Administration. Guidance on expanding the long-term care insurance pilots. . 2020. http://www.nhsa.gov.cn/art/2020/9/16/art_37_3586.html2024).
38.	National Healthcare Security Administration. National statistical bulletin on the development of the healthcare security service in 2022. 2022. http://www.nhsa.gov.cn/art/2023/7/10/art_7_10995.html.
39.	National Healthcare Security Administration. Notice on the issuance of the management measures for assessing the disability level of long-term care insurance (trial). 2023. http://www.nhsa.gov.cn/art/2023/12/15/art_104_11715.html.
40.	National Healthcare Security Administration. National professional standards for health care (long-term care) caregivers 2024. https://www.nhsa.gov.cn/art/2024/2/28/art_104_12122.html.
41.	National Healthcare Security Administration. Standardized service program coding and classification rules. 2025.
42.	Sun Q GF, Zhai T, et al,. A comparative study of long-term care insurance policies in China (in Chinese). Cooperative Economy and Science & Technology 2025; 06: 174–7.
43.	Ma C, Huo S, Chen H. Does integrated medical insurance system alleviate the difficulty of using cross-region health Care for the Migrant Parents in China--evidence from the China migrants dynamic survey. BMC health services research 2021; 21: 1-19.
44.	Fan X, Zhan HJ, Wang Q. The emergence of the eldercare industry in China: Progress and challenges. The Routledge Handbook of Social Care Work Around the World 2017: 203-17.
45.	Wong S. Ageing in place in China: Small facilities, community-family care integration, and governmental coordination. China Perspectives 2023; (134): 3-7.
46.	The State Council of the People’s Republic of China. Guideline aims at improving elderly services. 2025. https://english.www.gov.cn/policies/policywatch/202501/10/content_WS6780b58ac6d0868f4e8eea95.html.
47.	Powell J, Mackintosh S, Bird E, Ige J, Garrett H, Roys M. The role of home adaptations in improving later life. 2017.
48.	The State Council the People's Republic of China. 关于建立完善老年健康服务体系的指导意见. 2019. https://www.gov.cn/gongbao/content/2020/content_5483907.htm2024).
49.	Li X, Wang XS, Huang H, et al. National survey on the availability of oncology palliative care services at tertiary general and cancer hospitals in China. BMC Palliative Care 2023; 22(1): 144.
50.	Guangdong Provincial People's Government. 广东省加快推进养老服务发展若干措施的通知. http://www.gd.gov.cn/zwgk/wjk/qbwj/yfb/content/post_2702287.html (accessed 2022-02-05.
51.	Lu Y, Yu W, Zhang J, Li R. Advancements in hospice and palliative care in China: a five-year review. Asia-Pacific journal of oncology nursing 2024; 11(3): 100385.
52.	He Y, Zhao Y, Yao Y, et al. Cohort Profile: The China Hainan Centenarian Cohort Study (CHCCS). Int J Epidemiol 2018; 47(3): 694-5h.
53.	Liu Z, Wang Y, Zhang Y, et al. Cohort Profile: The Rugao Longevity and Ageing Study (RuLAS). Int J Epidemiol 2016; 45(4): 1064-73.
54.	Lv Y, Mao C, Yin Z, Li F, Wu X, Shi X. Healthy Ageing and Biomarkers Cohort Study (HABCS): a cohort profile. BMJ Open 2019; 9(10): e026513.
55.	Zeng Y, Nie C, Min J, et al. Sex differences in genetic associations with longevity. JAMA network open 2018; 1(4): e181670-e.
56.	Poulsen W, Christensen K, Dalgard C. Dietary patterns and survival to 100 + years: an empty systematic review of cohort and case-control studies. Arch Public Health 2022; 80(1): 161.
57.	Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011; 40(6): 1652-66.
58.	Bi Y, Lu J, Wang W, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes 2014; 6(2): 147-57.
59.	WHO. Ageing and health. 2022. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=Maintaining%20healthy%20behaviours%20throughout%20life,capacity%20and%20delaying%20care%20dependency.
60.	Healthy China 2030 Plan Blueprint. The State Coucil of China; 2017.
61.	Zhang P, He FJ, Li Y, et al. Reducing Salt Intake in China with “Action on Salt China” (ASC): Protocol for Campaigns and Randomized Controlled Trials. JMIR Research Protocols 2020; 9(4).
62.	China NHCotPsRo. Three-Year Weight Management Action Plan (2024–2026). 2024. https://english.www.gov.cn/news/202406/26/content_WS667c12e4c6d0868f4e8e8975.html (accessed May 16, 2025.
63.	de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med 2019; 381(26): 2541-51.
64.	Reimers CD, Knapp G, Reimers AK. Does physical activity increase life expectancy? A review of the literature. J Aging Res 2012; 2012: 243958.
65.	Partridge L, Fuentealba M, Kennedy BK. The quest to slow ageing through drug discovery. Nature Reviews Drug Discovery 2020; 19(8): 513-32.
66.	Aman Y, Schmauck-Medina T, Hansen M, et al. Autophagy in healthy aging and disease. Nature aging 2021; 1(8): 634-50.
67.	Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461(7265): 788-92.
68.	Dou Z, Ghosh K, Vizioli MG, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 2017; 550(7676): 402-6.
69.	Gulen MF, Samson N, Keller A, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 2023; 620(7973): 374-80.
70.	Yang JH, Hayano M, Griffin PT, et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023; 186(2): 305-26 e27.
71.	Walker KA, Chen J, Shi L, et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci Transl Med 2023; 15(705): eadf5681.
72.	Sun S, Li J, Wang S, et al. CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord. Nature 2023; 624(7992): 611-20.
73.	Zhang Y, Tang X, Wang Z, et al. The chemokine CCL17 is a novel therapeutic target for cardiovascular aging. Signal Transduction and Targeted Therapy 2023; 8: 157.
74.	Consortium AB, Bao H, Cao J, et al. Biomarkers of aging. Science China Life Sciences 2023; 66(5): 893-1066 
75.	Lim MY, Nam Y-D. Gut microbiome in healthy aging versus those associated with frailty. Gut Microbes 2023; 15(2): 2278225.
76.	Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013; 14(10): R115.
77.	Meyer DH, Schumacher B. BiT age: A transcriptome-based aging clock near the theoretical limit of accuracy. Aging Cell 2021; 20(3): e13320.
78.	Argentieri MA, Xiao S, Bennett D, et al. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. medRxiv 2023: 2023.09. 13.23295486.
79.	Woo J. Policy Implications of Population Ageing in Hong Kong in the UN Decade of Healthy Aging. American Journal of Medicine and Public Health 2023; 4(5): 1056.
80.	Chui CHK, Lu SY, Chan OF, et al. Changes in older adults? perceptions of age-friendliness in Hong Kong: A three-year mixed-methods study. Cities 2022; 127.
81.	Woo J. Aging in Place: Beyong the Home. In: Soon GC, Bodeker G, Kariippanon K, eds. Health Ageing in Asia Culture, Prevention and Wellness: CRC Press; 2022: 265-9.
82.	WHO. Integrated care for older people (ICOPE): guidance for person-centred assessment and pathways in primary care. https://www.who.int/publications/i/item/WHO-FWC-ALC-19.1 (Accessed on 29 Jan 2024). 2019.
83.	MHLW. An Outline of the Japanese Medical System. https://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/01_eng.pdf (accessed May 1 2024).
84.	JapanGov. Annual Report on the Ageing Society 2024 (Full Version), The State of Ageing and Implementation Status of Measures for the Ageing Society in FY2023, 2024.
85.	JapanGov. Annual Report on the Ageing Society 2023 (Full Version), The State of Aging and Implementation Status of Measures for the Ageing Society in FY2022, Chapter 3: Measures for an Aging Society in FY2023 (Section 2, Subsection 1) [Article in Japanese]. https://www8.cao.go.jp/kourei/whitepaper/w-2023/html/zenbun/s3_2_1.html (accessed May 29 2024).
86.	JapanGov. Annual Report on the Ageing Society 2023 (Full Version), The State of Aging and Implementation Status of Measures for the Ageing Society in FY2022, Chapter 3: Measures for an Aging Society in FY2023 (Section 2, Subsection 2) [Article in Japanese]. https://www8.cao.go.jp/kourei/whitepaper/w-2023/html/zenbun/s3_2_2.html (accessed May 29 2024).
87.	JapanGov. Annual Report on the Ageing Society 2023 (Full Version), The State of Aging and Implementation Status of Measures for the Ageing Society in FY2022, Chapter 3: Measures for an Aging Society in FY2023 (Section 2, Subsection 4) [Article in Japanese]. https://www8.cao.go.jp/kourei/whitepaper/w-2023/html/zenbun/s3_2_4.html (accessed May 29 2024).
88.	Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. The Lancet 2017; 389(10076): 1323-35.
89.	Ministry of Health and Welfare of Korea. Four significant tasks of medical reform. 2024. https://www.mohw.go.kr/menu.es?mid=a10715020000.
90.	Kim JI. Sociology of Longevity: Socioecological Factors of Survival Probability: Cambridge Scholars Publishing London; 2022.
91.	Zhan S, Huang L. State familism in action: aging policy and intergenerational support in Singapore. China Population and Development Studies 2023; 7(2): 111-29.
92.	Chen C, Lim J, Visaria A, Chan A. Societal Aging and its Impact on Singapore: National Bureau of Economic Research, 2023.
93.	Satchanawakul N, Liangruenrom N, Thang LL, Satchanawakul N. Systematic scoping review of ageing in place strategies in Japan, Singapore and Thailand: A comparative analysis. Australasian Journal on Ageing 2024.
94.	OECD. Who cares? Attracting and retaining care workers for the elderly. OECD iLibrary Paris, France; 2020.
95.	Rostgaard T, Jacobsen F, Kröger T, Peterson E. Revisiting the Nordic long-term care model for older people—still equal? European Journal of Ageing 2022; 19(2): 201-10.
96.	Hjelmar U, Rostgaard T. Supplemental home care and topping‐up: A shift from service universalism towards a new and privatised public service model? International journal of social welfare 2020; 29(2): 118-28.
97.	Morgan F, Zechner M. Uncovering familialism: cash-for-care schemes in England and Finland. International Journal of Care and caring 2022; 6(4): 510-27.
98.	Rapeli M, Carlstedt J, Hergeirsdóttir R, Guðmundsson HS, Cuadra CB, Hatakka I. Three Nordic countries responding to COVID-19–Eldercare perspectives. International Journal of Disaster Risk Reduction 2023; 84: 103442.
99.	Alexopoulou S, Åström J. How the Responsibility of Digital Support for Older People is Allocated? The Swedish Welfare System at the Crossroads. Research on Ageing and Social Policy 2022; 10(1): 48-76.
100.	Lei X, Bai C, Hong J, Liu H. Long-term care insurance and the well-being of older adults and their families: evidence from China. Social Science & Medicine 2022; 296: 114745.
101.	Chen S, Li L, Jiao L, Wang C. Long-term care insurance and the future of healthy aging in China. Nature Aging 2023; 3(12): 1465-8.
102.	Chen S, Li L, Jiao L, et al. Long-term care insurance in China: Current challenges and recommendations. Journal of Global Health 2024; 14: 03015.
103.	Temsumrit N. Can aging population affect economic growth through the channel of government spending? Heliyon 2023; 9(9).
104.	Nan Y, Del Ser J, Walsh S, et al. Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions. Information Fusion 2022; 82: 99-122.
105.	Aman Y, Frank J, Lautrup SH, et al. The NAD(+)-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications. Mech Ageing Dev 2020; 185: 111194.
106.	Ruixue A, Xurui J, Bowen T, Guang Y, Zhangming N, Fang EF. Ageing and Alzheimer’s disease: Application of artificial intelligence in mechanistic studies, diagnosis, and drug development.: Cham: Springer International Publishing; 2022.
107.	Frohlich H, Balling R, Beerenwinkel N, et al. From hype to reality: data science enabling personalized medicine. BMC Med 2018; 16(1): 150.
108.	Egholt Søgaard J, Roine J, Robling P, et al. Nordic Economic Policy Review 2018: Increasing Income Inequality in the Nordics. Nordisk Ministerråd; 2018.
109.	Kim M, Seol J, Sato T, Fukamizu Y, Sakurai T, Okura T. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients 2022; 14(4).
110.	Katayoshi T, Uehata S, Nakashima N, et al. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep 2023; 13(1): 2786.
111.	Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging 2022; 8(1): 5.
112.	Akasaka H, Nakagami H, Sugimoto K, et al. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatr Gerontol Int 2023; 23(1): 38-43.
113.	Pencina KM, Valderrabano R, Wipper B, et al. Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study. J Clin Endocrinol Metab 2023; 108(8): 1968-80.
114.	Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr 2018; 108(2): 343-53.
115.	Presterud R, Deng WH, Wennerstrom AB, et al. Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia. Mov Disord 2024; 39(2): 360-9.
116.	Brakedal B, Dolle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab 2022; 34(3): 396-407 e6.
117.	Yulug B, Altay O, Li X, et al. Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Transl Neurodegener 2023; 12(1): 4.
118.	Nambiar A, Kellogg D, 3rd, Justice J, et al. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. EBioMedicine 2023; 90: 104481.
119.	Gonzales MM, Garbarino VR, Kautz TF, et al. Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Nat Med 2023; 29(10): 2481-8.
120.	Crespo-Garcia S, Fournier F, Diaz-Marin R, et al. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nat Med 2024; 30(2): 443-54.
121.	Farsad-Naeimi A, Alizadeh M, Esfahani A, Darvish Aminabad E. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct 2018; 9(4): 2025-31.
122.	Lee DJ, Kuerec AH, Maier AB. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. The Lancet Healthy Longevity 2024; 5(2): e152-e62.
123.	Luo S, Wong ICK, Chui CSL, et al. Effects of putative metformin targets on phenotypic age and leukocyte telomere length: a mendelian randomisation study using data from the UK Biobank. The Lancet Healthy Longevity 2023; 4(7): e337-e44.
124.	Zhang X-L, Yuan S-Y, Wan G, et al. The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24). Scientific Reports 2021; 11(1): 4839.
125.	Schwarz C, Benson GS, Horn N, et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline: a randomized clinical trial. JAMA network open 2022; 5(5): e2213875-e.
126.	Liu S, D’Amico D, Shankland E, et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial. JAMA network open 2022; 5(1): e2144279-e.
127.	Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. The British Journal of Psychiatry 2019; 215(5): 668-74.